• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Lung Cancer

Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities

by Fred Pennic 01/31/2025 Leave a Comment

Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities

What You Should Know:  - Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.  - The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare, making it more accessible and affordable for healthcare providers and patients. AI-Powered Lung Nodule Analysis Lung cancer remains a leading cause of cancer-related deaths worldwide, but screening rates remain
Read More

PrognomiQ Raises $34M to Advance Multi-Omics Early Detection Test for Lung Cancer

by Fred Pennic 11/05/2024 Leave a Comment

PrognomiQ Raises $34M to Advance Multi-Omics Early Detection Test for Lung Cancer

What You Should Know:  - PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing investors including Catalio Capital Management, aMoon, Invus and Bruker.   - The funding brings PrognomiQ’s total funding to more than $135M and will accelerate the development of PrognomiQ's early detection test for lung cancer. Enhancing Lung
Read More

Nebraska Medicine & CancerIQ Boost Lung Cancer Risk Assessments by 6x

by Syed Hamza Sohail 10/09/2024 Leave a Comment

Nebraska Medicine & CancerIQ Boost Lung Cancer Risk Assessments by 6x

What You Should Know: -  Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused precision health platform. -  The results of the lung cancer early detection campaign, which focused on risk assessment outside of the clinical setting, will be presented at the upcoming Association of Cancer Care Centers (ACCC) National
Read More

AI Breakthrough for Lung Disease: Thirona’s LungQ Receives FDA Clearance

by Jasmine Pennic 01/23/2024 Leave a Comment

AI Breakthrough for Lung Disease: Thirona's LungQ Receives FDA Clearance

What You Should Know: - Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update, v3.0.0. - This FDA clearance paves the way for American hospitals to now harness the software's advanced capabilities, marking a significant step forward in lung disease diagnosis and treatment. LungQ 3.0.0: Precision Navigation for Lung Interventions This latest
Read More

Sheba Medical Deploys AI Lung Cancer Diagnostics Platform

by Fred Pennic 08/08/2023 Leave a Comment

Sheba Medical Center to Create The First Fully VR-Based Hospital In The World Sheba Medical Center Declares Israel’s “City of Health”, Inks $350M Deal

What You Should Know:  - Sheba Medical Center, Israel’s largest medical center, today announced the deployment of a new accelerated, AI-powered cancer diagnostics research platform that can shorten diagnostic time from three weeks to minutes. - The platform integrates technology developed by Sheba, in addition to innovative digital health startups, to accelerate the pathology department’s diagnostic capabilities.  - The first algorithm incorporated, developed by precision oncology
Read More

Notable Leverages GPT to Automate Patient Front Office Experience

by Jasmine Pennic 04/13/2023 Leave a Comment

Notable Leverages GPT to Automate Patient Front Office Experience

What You Should Know: Notable, an intelligent automation company for healthcare, launches Patient AI, a solution leveraging large language models (LLMs) and GPT (the technology powering ChatGPT) to bring personalization at scale to healthcare.Using GPT to scan existing clinical documentation, this tech can detect missed diagnoses, identify lapsed insurance cards, incorrect addresses, eligible clinical trials, or costly care gaps in real-time across an entire patient population.  How
Read More

Protai Raises $20M to Build an Oncology Drug Discovery Pipeline

by Syed Hamza Sohail 03/15/2023 Leave a Comment

Protai Raises $20M to Build an Oncology Drug Discovery Pipeline

What You Should Know: - Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, today announced a $12 million extension of its seed round, bringing the total amount to $20M. - The round includes existing investors Grove Ventures and Pitango Healthcare and was joined by Copenhagen-based Maj Invest Equity Fund. The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data
Read More

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

by Fred Pennic 02/16/2023 Leave a Comment

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Today, cancer is the second leading cause of death in the United States. Sadly, cancer disparities exist, with racial/ethnic minority, low-income, and uninsured populations suffering the greatest burden. That’s why routine cancer screening is critical to addressing cancer disparities as they have the potential to greatly reduce both incidence and mortality rates. To address this, Federally qualified health centers (FQHCs) are funded by the Health Resources and Services Administration to provide
Read More

Biden Admin Builds on Cancer Moonshot with 13 More Initiatives

by Syed Hamza Sohail 02/06/2023 Leave a Comment

Biden Admin Builds on Cancer Moonshot with 13 More Initiatives

What You Should Know: - One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today. - The Cancer Moonshot has spurred tremendous action across the federal government and from the public and private
Read More

Is AI-Assisted Lung Cancer Diagnosis Right For Your Hospital?

by Ryan Hennen, VP of US Sales at Optellum 01/24/2023 Leave a Comment

Is AI-assisted lung cancer diagnosis right for your hospital?

Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from this disease each year. Most patients are diagnosed after symptoms have appeared and the disease has progressed to an advanced stage (Stage III or IV), which explains the current worldwide five-year survival rate of just 20 percent. In contrast, the survival rate for small lung tumors that are treated at Stage 1A is as high as 90 percent. This significant difference highlights a critical
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |